Literature DB >> 15331582

Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasma.

Xinyi Zhang1, Sau-Mei Leung, Claudia R Morris, Mark K Shigenaga.   

Abstract

The advantage of using proteins and peptides as biomarkers is that they can be found readily in blood, urine, and other biological fluids. Such sample types are easily obtained and represent a potentially rich palette of biologically informative molecules. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) represents a key tool for rapidly interrogating such sample types. The goal of clinical proteomics is to harness the power of this tool for identifying novel, condition-specific protein fingerprints that may, in turn, lead to the elucidation and use of diseasespecific biomarkers that may be used to diagnose disease as well as to evaluate disease severity, disease progression, and intervention efficacy. Here we have evaluated a simple, affordable bench-top MALDI-TOF mass spectrometer to generate protein profiles from human plasma samples of asthma patients and healthy individuals. We achieve this profiling by using C8-functionalized magnetic beads that enrich a specific subset of plasma proteins based on their absorption by this resin. This step is followed by elution, transfer onto a prestructured sample support (AnchorChip technology), and analysis in a bench-top MALDI-TOF mass spectrometer (OmniFLEX) with AutoXecute acquisition control which enables automated operation with reproducible results. Resulting spectra are compiled and analyzed through the pattern recognition component of ClinProTools software. This approach in combination with ClinProTools software permits the investigator to rapidly scan for potential biomarker peptides/proteins in human plasma. The reproducibility of plasma profiles within and between days has been evaluated. The results show that the novel and facile approach with manual magnetic-bead sample preparation and a low-cost bench-top MALDI-TOF mass spectrometer is suitable for preliminary biomarker discovery studies. Copyright 2004 ABRF

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331582      PMCID: PMC2291685     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  5 in total

1.  Prestructured MALDI-MS sample supports.

Authors:  M Schuerenberg; C Luebbert; H Eickhoff; M Kalkum; H Lehrach; E Nordhoff
Journal:  Anal Chem       Date:  2000-08-01       Impact factor: 6.986

Review 2.  Mass spectrometry-based clinical proteomics.

Authors:  Wolfgang Pusch; Mark T Flocco; Sau-Mei Leung; Herbert Thiele; Markus Kostrzewa
Journal:  Pharmacogenomics       Date:  2003-07       Impact factor: 2.533

3.  Clinical proteomics: written in blood.

Authors:  Lance A Liotta; Mauro Ferrari; Emanuel Petricoin
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

4.  Alpha-cyano-4-hydroxycinnamic acid affinity sample preparation. A protocol for MALDI-MS peptide analysis in proteomics.

Authors:  J Gobom; M Schuerenberg; M Mueller; D Theiss; H Lehrach; E Nordhoff
Journal:  Anal Chem       Date:  2001-02-01       Impact factor: 6.986

Review 5.  Heterogeneity in the pathology and treatment of asthma.

Authors:  Stephen P Peters
Journal:  Am J Med       Date:  2003-08-18       Impact factor: 4.965

  5 in total
  17 in total

Review 1.  Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.

Authors:  Fulvio Magni; Yuri E M Van Der Burgt; Clizia Chinello; Veronica Mainini; Erica Gianazza; Valeria Squeo; André M Deelder; Marzia Galli Kienle
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

Review 2.  [Proteome analysis--basis for individualized pancreatic carcinoma therapy?].

Authors:  J M Löhr; R Faissner; P Findeisen; M Neumaier
Journal:  Internist (Berl)       Date:  2006-06       Impact factor: 0.743

3.  Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range.

Authors:  Christine L Gatlin-Bunai; Lisa H Cazares; William E Cooke; Oliver J Semmes; Dariya I Malyarenko
Journal:  J Proteome Res       Date:  2007-10-05       Impact factor: 4.466

4.  Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.

Authors:  Hiroshi Umemura; Akira Togawa; Kazuyuki Sogawa; Mamoru Satoh; Kaoru Mogushi; Motoi Nishimura; Kazuyuki Matsushita; Hiroshi Tanaka; Hirotaka Takizawa; Yoshio Kodera; Fumio Nomura
Journal:  J Gastroenterol       Date:  2011-02-05       Impact factor: 7.527

5.  Assessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery.

Authors:  Ediri Sideso; Michalis Papadakis; Cynthia Wright; Ashok Handa; Alastair Buchan; Benedikt Kessler; James Kennedy
Journal:  Transl Stroke Res       Date:  2010-08-14       Impact factor: 6.829

6.  Endogenous plasma Peptide detection and identification in the rat by a combination of fractionation methods and mass spectrometry.

Authors:  Fabrice Bertile; Flavie Robert; Véronique Delval-Dubois; Sarah Sanglier; Christine Schaeffer; Alain Van Dorsselaer
Journal:  Biomark Insights       Date:  2007-10-09

7.  Proteomic patterns analysis with multivariate calculations as a promising tool for prompt differentiation of early stage lung tissue with cancer and unchanged tissue material.

Authors:  Piotr Waloszczyk; Tomasz Janus; Jacek Alchimowicz; Tomasz Grodzki; Krzysztof Borowiak
Journal:  Diagn Pathol       Date:  2011-03-21       Impact factor: 2.644

8.  MALDI profiling of human lung cancer subtypes.

Authors:  Angelo Gámez-Pozo; Iker Sánchez-Navarro; Manuel Nistal; Enrique Calvo; Rosario Madero; Esther Díaz; Emilio Camafeita; Javier de Castro; Juan Antonio López; Manuel González-Barón; Enrique Espinosa; Juan Angel Fresno Vara
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

9.  Leptospira spp. strain identification by MALDI TOF MS is an equivalent tool to 16S rRNA gene sequencing and multi locus sequence typing (MLST).

Authors:  Anna Rettinger; Inke Krupka; Karola Grünwald; Viktor Dyachenko; Volker Fingerle; Regina Konrad; Heribert Raschel; Ulrich Busch; Andreas Sing; Reinhard K Straubinger; Ingrid Huber
Journal:  BMC Microbiol       Date:  2012-08-27       Impact factor: 3.605

Review 10.  The proteomics big challenge for biomarkers and new drug-targets discovery.

Authors:  Rocco Savino; Sergio Paduano; Mariaimmacolata Preianò; Rosa Terracciano
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.